Racing Medication and Testing Consortium

Racing Medication and Testing Consortium

The RMTC has selected Dr. Michael Hardy to serve as its executive director.

a field of horses race to the finish line

text size

The Racing Medication & Testing Consortium (RMTC) has hired Dr. Michael Hardy to serve as its executive director.

In this role, Dr. Hardy will manage the RMTC’s Laboratory Accreditation and External Quality Assurance Program in conjunction with the new Horseracing Integrity and Welfare Unit.  He will also be charged with the administration of the RMTC’s Scientific Advisory Committee process, the monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, administrative oversight of RMTC-funded research projects, and coordinating RegVet CE programs.  In the near term, Dr. Hardy will lead the efforts of the RMTC to educate Thoroughbred racing participants concerning the significant changes in the regulation of anti-doping and medication control to begin on January 1, 2023 with the implementation of the new Horseracing Integrity and Safety Authority ADMC program.

The RMTC selected Dr. Hardy based on his experience in developing regulatory safety initiative(s) for racehorses, management of pre- and post-race drug testing, research into emerging threats to the integrity of horse racing, and the regulation of horse racing in general. 

“We are very pleased to have Dr. Hardy on board,” said RMTC chair Alex Waldrop. “He has been working with the RMTC for years now, and that will enable him to hit the ground running in this new capacity, at a pivotal time for the RMTC and the entire horse racing industry.”

Hardy also continues in his position as chief association veterinarian, and newly appointed safety director for Horseshoe Indianapolis, and as a member of the Breeders’ Cup Veterinary Panel.

Dr. Hardy started his career as a racing regulatory veterinarian in 2008, first for the Kentucky Horse Racing Commission and subsequently since 2013 for Horseshoe Indianapolis (previously Indiana Grand Racing & Casino). 

Hardy has served on the RMTC Horseracing Testing Laboratory Committee (HTLC) since 2019, where he has assisted in the implementation of the Laboratory Accreditation Program.   The HTLC serves as a consultant to the RMTC Board and Executive Committee on matters related to the Laboratory Accreditation Program and RMTC-accredited laboratories.

In addition, he has also presented at various veterinary and industry-related conferences, including RMTC’s RegVet CE, on topics of  pre-race examinations, injury prevention, emergency response , race-day injury management, and horse racing testing laboratory accreditation. 

The RMTC is a 501(c) 3 organization comprised of 23 industry stakeholder organizations with a shared commitment to engage in research, education, and advocacy for science-based initiatives that promote the health and safety of the racehorse and the integrity of competition.  More information can be found at

AQHA News and information is a service of the American Quarter Horse Association. For more news and information, follow @AQHA Racing on Twitter, "like" Q-Racing on Facebook, and visit